Novo Nordisk
NVO
#21
Rank
$457.51 B
Marketcap
$105.27
Share price
2.57%
Change (1 day)
1.62%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Market capitalization of Novo Nordisk (NVO)

Market cap: $457.51 Billion USD

As of November 2024 Novo Nordisk has a market cap of $457.51 Billion USD. This makes Novo Nordisk the world's 21th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Novo Nordisk from 1996 to 2024

End of year Market Cap

Year Marketcap Change
2024$457.51 B-0.8%
2023$461.21 B51.46%
2022$304.50 B19.38%
2021$255.07 B56.42%
2020$163.07 B17.22%
2019$139.12 B24.43%
2018$111.80 B-14.74%
2017$131.12 B39.24%
2016$94.17 B-38.17%
2015$152.30 B35.23%
2014$112.62 B11.3%
2013$101.18 B11.24%
2012$90.96 B36.37%
2011$66.70 B-1.24%
2010$67.54 B66.85%
2009$40.48 B24.25%
2008$32.58 B-22.36%
2007$41.96 B58.17%
2006$26.53 B45.63%
2005$18.21 B1.1%
2004$18.02 B27.41%
2003$14.14 B40.56%
2002$10.06 B-27.62%
2001$13.90 B12.46%
2000$12.36 B34.85%
1999$9.16 B-4.91%
1998$9.64 B-10.92%
1997$10.82 B54.34%
1996$7.01 B

End of Day market cap according to different sources

On Nov 20th, 2024 the market cap of Novo Nordisk was reported to be:

$454.56 Billion USD
by Yahoo Finance info icon info icon
$454.56 Billion USD
by CompaniesMarketCap info icon info icon
$469.85 Billion USD
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
$141.33 B-69.11%๐Ÿ‡บ๐Ÿ‡ธ USA
$715.22 B 56.33%๐Ÿ‡บ๐Ÿ‡ธ USA
$117.39 B-74.34%๐Ÿ‡บ๐Ÿ‡ธ USA
$121.13 B-73.52%๐Ÿ‡ซ๐Ÿ‡ท France